Geovax Labs Stock Performance
| GOVX Stock | USD 2.70 0.31 10.30% |
The company retains a Market Volatility (i.e., Beta) of 2.17, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, GeoVax Labs will likely underperform. At this point, GeoVax Labs has a negative expected return of -0.52%. Please make sure to check out GeoVax Labs' jensen alpha, kurtosis, as well as the relationship between the Kurtosis and price action indicator , to decide if GeoVax Labs performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days GeoVax Labs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Actual Historical Performance (%)
One Day Return (4.61) | Five Day Return 9.58 | Year To Date Return (48.27) | Ten Year Return (99.98) | All Time Return (99.98) |
Last Split Factor 1:15 | Dividend Date 2020-09-25 | Last Split Date 2024-01-31 |
1 | GeoVax Labs, Inc. A Hot Penny Stock On The Move | 09/04/2024 |
2 | GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference | 10/02/2024 |
3 | Acquisition by Reynolds Mark of 128000 shares of GeoVax Labs at 2.79 subject to Rule 16b-3 | 10/18/2024 |
4 | GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024 | 11/05/2024 |
5 | GeoVax Labs, Inc. Q3 2024 Earnings Call Transcript | 11/13/2024 |
6 | ARMISTICE CAPITAL, LLC Expands Stake in Geovax Labs Inc | 11/15/2024 |
7 | Alliance Global Partners Initiates Coverage of GeoVax Labs with Buy Recommendation - MSN | 11/20/2024 |
| Begin Period Cash Flow | 27.6 M |
GeoVax |
GeoVax Labs Relative Risk vs. Return Landscape
If you would invest 500.00 in GeoVax Labs on August 28, 2024 and sell it today you would lose (230.00) from holding GeoVax Labs or give up 46.0% of portfolio value over 90 days. GeoVax Labs is currently does not generate positive expected returns and assumes 10.2641% risk (volatility on return distribution) over the 90 days horizon. In different words, 91% of stocks are less volatile than GeoVax, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
GeoVax Labs Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for GeoVax Labs' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as GeoVax Labs, and traders can use it to determine the average amount a GeoVax Labs' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.051
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GOVX |
Estimated Market Risk
| 10.26 actual daily | 91 91% of assets are less volatile |
Expected Return
| -0.52 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average GeoVax Labs is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of GeoVax Labs by adding GeoVax Labs to a well-diversified portfolio.
GeoVax Labs Fundamentals Growth
GeoVax Stock prices reflect investors' perceptions of the future prospects and financial health of GeoVax Labs, and GeoVax Labs fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on GeoVax Stock performance.
| Return On Equity | -3.62 | ||||
| Return On Asset | -1.34 | ||||
| Operating Margin | (16.84) % | ||||
| Current Valuation | 26.98 M | ||||
| Shares Outstanding | 9.44 M | ||||
| Price To Earning | (1.25) X | ||||
| Price To Book | 3.34 X | ||||
| Price To Sales | 94.46 X | ||||
| Gross Profit | 81.53 K | ||||
| EBITDA | (26.67 M) | ||||
| Net Income | (25.97 M) | ||||
| Cash And Equivalents | 30.9 M | ||||
| Cash Per Share | 1.25 X | ||||
| Total Debt | 3.52 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 9.51 X | ||||
| Book Value Per Share | 2.92 X | ||||
| Cash Flow From Operations | (25.17 M) | ||||
| Earnings Per Share | (8.39) X | ||||
| Market Capitalization | 28.4 M | ||||
| Total Asset | 9.28 M | ||||
| Retained Earnings | (104.36 M) | ||||
| Working Capital | 4.37 M | ||||
| Current Asset | 1.24 M | ||||
| Current Liabilities | 126.99 K | ||||
About GeoVax Labs Performance
Evaluating GeoVax Labs' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if GeoVax Labs has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if GeoVax Labs has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (1.32) | (1.26) | |
| Return On Tangible Assets | (2.80) | (2.94) | |
| Return On Capital Employed | (4.64) | (4.41) | |
| Return On Assets | (2.80) | (2.94) | |
| Return On Equity | (4.51) | (4.28) |
Things to note about GeoVax Labs performance evaluation
Checking the ongoing alerts about GeoVax Labs for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for GeoVax Labs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| GeoVax Labs generated a negative expected return over the last 90 days | |
| GeoVax Labs has high historical volatility and very poor performance | |
| GeoVax Labs has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (25.97 M) with profit before overhead, payroll, taxes, and interest of 81.53 K. | |
| GeoVax Labs currently holds about 30.9 M in cash with (25.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.25. | |
| GeoVax Labs has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Alliance Global Partners Initiates Coverage of GeoVax Labs with Buy Recommendation - MSN |
- Analyzing GeoVax Labs' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether GeoVax Labs' stock is overvalued or undervalued compared to its peers.
- Examining GeoVax Labs' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating GeoVax Labs' management team can have a significant impact on its success or failure. Reviewing the track record and experience of GeoVax Labs' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of GeoVax Labs' stock. These opinions can provide insight into GeoVax Labs' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for GeoVax Stock Analysis
When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.